SynthesisBMC nutrition2025
The effect of pomegranate products on glycemic profile in adults: a GRADE- assessed systematic review and dose-response meta-analysis of randomized controlled trials.
Synthesis in BMC nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Next-Generation Dietary Antioxidants in Women's Reproductive Health: Mechanisms, Reproductive Outcomes, and Therapeutic Potential.Antioxidants (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPomegranate consumption may have a beneficial effect on glucose control and insulin resistance due to its bioactive compounds. However, the results of available clinical trials are inconsistent. To address these inconsistencies, we conducted a meta-analysis of 34 randomized clinical trials (RCTs) evaluating the effects of pomegranate on glycemic parameters in adults.
methodsA thorough search was conducted across multiple databases until December 2024 to identify trials that investigated the impact of pomegranate on glucose control and insulin sensitivity. We calculated the effect size, reported as the weighted mean difference (WMD) with 95% confidence intervals (CIs), based on the net changes in fasting blood glucose (FBS), insulin, HOMA-IR, and Hemoglobin A1c (HbA1c).
resultsAmong the 407 records, this meta-analysis included 34 eligible RCTs involving 1500 participants. Pomegranate consumption was significantly associated with a reduction in FBS (WMD: -3.036 mg/dl; 95% CI, -4.273 to -1.799, P < 0.001, Tau
conclusionThis meta-analysis suggests that the consumption of pomegranate products can result in positive effects on FBS, insulin levels, HOMA-IR, and QUICKI in adults. More RCTs with longer duration and larger sample sizes are needed to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.